BioNTech
and global collaboration programs in infectious diseases influenza | BioNTech
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
63 of 156
Related slides by other companies
RenovoRx
IPO
August 2021
designed for success expect one phase trial will lead to approval and commercial adoption | RenovoRx
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
MAIA Biotechnology
Investor Presentation
November 2023
thio trial planned a | MAIA Biotechnology
Theravance Biopharma
Results
May 2023
progress against targets | Theravance Biopharma
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Results
March 2022
Investor Day
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights